CRISPR Therapeutics (CRSP) operating margin

Operating margin · fiscal 2024
-1333.0%

CRISPR Therapeutics (CRSP) had an operating margin of -1333.0% in fiscal 2024 (the year ended December 31, 2024). That is 1272.9 percentage points lower than the -60.1% of fiscal 2023. Figures as of 17 Nov 2026, 22:02 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Operating margin, fiscal 2024
-1333.0%
Change on fiscal 2023
−1272.9 pts
Highest on record
40.8%fiscal 2021
Lowest on record
-154394.7%fiscal 2022
Fiscal years on record
102015–2024

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

CRISPR Therapeutics operating margin, in more detail

Across the 10 fiscal years on record (2015–2024), the highest was 40.8% in fiscal 2021 and the lowest -154394.7% in fiscal 2022. The fiscal 2024 figure is higher than in 44% of the 9 earlier fiscal years on record, whose median is -1319.3%.

Gross margin was -244.8% in fiscal 2024. Net margin was -1046.4% in fiscal 2024.

History · 10 fiscal years

Operating margin by fiscal year

  • Operating margin
  • Gross margin
  • Net margin

CRISPR Therapeutics operating margin, year by year

CRISPR Therapeutics (CRSP) operating margin by fiscal year
Fiscal yearOperating marginChangeYear endedGross marginNet margin
2024-1333.0% 1272.9 pts down-244.8%-1046.4%
2023-60.1% 154334.6 pts up64.8%-41.5%
2022-154394.7% 154435.5 pts down-25186.7%-149122.7%
202140.8% 49336.4 pts up—41.3%
2020-49295.5% 49311.7 pts down—-48520.9%
201916.1% 5103.9 pts up—23.1%
2018-5087.8% 4930.1 pts down—-5281.1%
2017-157.7% 1161.6 pts up—-166.7%
2016-1319.3% 9097.3 pts up—-448.8%
2015-10416.6%——-10325.1%

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

How to read it

It shows how much of each unit of sales survives the cost of running the business — rising margins point to pricing power or scale, falling ones to pressure.

Operating margin at health care companies of similar size

Operating margin of CRISPR Therapeutics and comparable companies
CompanyOperating marginFiscal year
MiniMed Group MMED-5.1%2026
Adaptive Biotechnologies ADPT-20.6%2025
Heartflow HTFL-36.4%2025
CRISPR Therapeutics CRSP-1333.0%2024
Travere Therapeutics TVTX-12.8%2025
Option Care Health OPCH6.0%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on CRSP

CRISPR Therapeutics, figure by figure

CRISPR Therapeutics (CRSP) overview: price, valuation and scorecardAll health care companies by market value

CRISPR Therapeutics operating margin: questions and answers

What is CRISPR Therapeutics's operating margin?

CRISPR Therapeutics (CRSP) had an operating margin of -1333.0% in fiscal 2024 (the year ended December 31, 2024). That is 1272.9 percentage points lower than the -60.1% of fiscal 2023.

Is CRISPR Therapeutics's operating margin high or low compared with its own history?

The fiscal 2024 figure is higher than in 44% of the 9 earlier fiscal years on record, whose median is -1319.3%.

What are the highest and lowest operating margin figures on record for CRISPR Therapeutics?

Across the 10 fiscal years on record (2015–2024), the highest was 40.8% in fiscal 2021 and the lowest -154394.7% in fiscal 2022.

What are CRISPR Therapeutics's gross and net margins?

Gross margin was -244.8% in fiscal 2024. Net margin was -1046.4% in fiscal 2024.

How is CRISPR Therapeutics's operating margin calculated?

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “CRISPR Therapeutics (CRSP) operating margin”, data as of 17 November 2026. https://funkfolio.com/stock/CRSP/operating-margin

Underlying data: the company's filings with the SEC and Yahoo Finance.